Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21111784 | 1.00 | DRD1 (0.51) | DRD1 | |
| SCHEMBL708320 | 0.90 | DRD1 (0.61) | DRD1 | |
| SCHEMBL21111854 | 0.86 | DRD1 (0.55) | DRD1 | |
| SCHEMBL29501652 | 0.86 | DRD1 (0.55) | DRD1 | |
| SCHEMBL29501658 | 0.86 | DRD1 (0.55) | DRD1 | |
| SCHEMBL29501639 | 0.86 | DRD1 (0.51) | DRD1 | |
| SCHEMBL21111795 | 0.86 | DRD1 (0.51) | DRD1 | |
| SCHEMBL21111888 | 0.85 | DRD1 (0.57) | DRD1 | |
| SCHEMBL16512009 | 0.85 | DRD1 (0.56) | DRD1 | |
| SCHEMBL31758911 | 0.84 | DRD1 (0.49) | DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250171390-A1 | PROCESS FOR PREPARING UNSATURATED ALDEHYDES | FIRMENICH SA (CH) | 2025-05-29 | — | — | US | disclosed |
| US-20250154090-A1 | PROCESS FOR PREPARING GAMMA,DELTA-UNSATURATED ALDEHYDES DERIVATIVES | FIRMENICH SA (CH) | 2025-05-15 | — | — | US | disclosed |
| EP-4486717-A1 | PROCESS FOR PREPARING GAMMA,DELTA-UNSATURATED ALDEHYDES DERIVATIVES | Firmenich SA (CH) | 2025-01-08 | — | — | EP | disclosed |
| EP-4486732-A1 | PROCESS FOR PREPARING UNSATURATED ALDEHYDES | Firmenich SA (CH) | 2025-01-08 | — | — | EP | disclosed |
| CN-118829633-A | Process for preparing unsaturated aldehydes | 弗门尼舍有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118804908-A | Process for preparing gamma, delta-unsaturated aldehyde derivatives | 弗门尼舍有限公司 | 2024-10-18 | — | — | CN | disclosed |
| US-20230365523-A1 | PROCESS FOR PREPARING 3-(CYCLOHEX-1-EN-1-YL)PROPANAL DERIVATIVES | FIRMENICH SA (CH) | 2023-11-16 | — | — | US | disclosed |
| WO-2023166005-A1 | PROCESS FOR PREPARING UNSATURATED ALDEHYDES | FIRMENICH SA (CH) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023166004-A1 | PROCESS FOR PREPARING GAMMA,DELTA-UNSATURATED ALDEHYDES DERIVATIVES | FIRMENICH SA (CH) | 2023-09-07 | — | — | WO | disclosed |
| CN-116018334-A | Process for preparing 3- (cyclohex-1-en-1-yl) propanal derivatives | 弗门尼舍有限公司 | 2023-04-25 | — | — | CN | disclosed |
| EP-4153552-A2 | PROCESS AND INTERMEDIATES FOR PREPARING 3-(CYCLOHEX-1-EN-1-YL) PROPANAL DERIVATIVES | Firmenich SA (CH) | 2023-03-29 | — | — | EP | disclosed |
| WO-2022049036-A2 | PROCESS FOR PREPARING 3-(CYCLOHEX-1-EN-1-YL)PROPANAL DERIVATIVES | FIRMENICH SA (CH) | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250154090-A1 | PROCESS FOR PREPARING GAMMA,DELTA-UNSATURATED ALDEHYDES DERIVATIVES | DEGS1, EBP, FASN | DRD1 1505/4885 |
| US-20250171390-A1 | PROCESS FOR PREPARING UNSATURATED ALDEHYDES | ALDH1A1, AOX1, ALDH2 | DRD1 2137/4885 |
| US-20230365523-A1 | PROCESS FOR PREPARING 3-(CYCLOHEX-1-EN-1-YL)PROPANAL DERIVATIVES | CYP1A1, CYP51A1, HPD | DRD1 1016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.